KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Celltrion

Celltrion to Conduct Trials for COVID-19 Test Kit, Cure in Six months

James Jung by James Jung
PUBLISHED: March 13, 2020 UPDATED: March 18, 2020
in Celltrion, South Korea, Virus
0
celltrion-chairman
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion

Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion

Celltrion, South Korea’s leading biosimilar developer, said it doubled its efforts to create a super-fast test kit designed to identify COVID-19 and to develop a cure, which the company foresees would reach human clinical trial stage within six months.

 Seo Jung-jin, Celltrion’s Chairman, shared on a YouTube live stream on Thursday the group’s ongoing efforts on the coronavirus cure development. He said that the company aims to commercialize the kit within three months with a local partner.

Seo said that under normal circumstances, the process would take about 18 months, though, given the emergency in South Korea, they plan to initiate the use of antibodies on confirmed patients after six months. Celltrion would closely work with the Ministry of Food and Drug Safety to conduct the trials.

Celltrion secured a blood sample from a recovered coronavirus patient released from the Seoul National University College of Medicine. The company has also been gathering more samples from other institutes to use for screening antibodies required for the diagnostic kits. The biosimilar developer hopes to narrow down the antibody candidates by the end of March and select the most potent pipeline by the end of April.

The chairman said that as they are developing a cure, they would also develop diagnostic kits that can be used by people without the intervention of a medical professional.

Diasgnostic Kits

Hospitals widely use a method called quantitative reverse transcription PCR (RT-qPCR), but it takes a few hours to acquire results with very high accuracy. Meanwhile, a rapid diagnostic kit works faster but has low accuracy.

Celltrion intends to combine both methods benefiting from their advantages. The company plans to create a kit that could show results within 15 to 20 minutes with high accuracy.

Seo added that the company plans to conduct a phase 1 study to demonstrate safety, and a phase 3 trial for both safety and efficacy and side effects in up to 1,000 patients.

Furthermore, Celltrion would provide a total of 1 million masks to citizens of Cheongju, North Chungcheong Province, and Incheon, Gyeonggi Province. Both cities are where Celltrion’s operation facilities are located, said Seo.

Seo said that the commercial development of the new coronavirus treatment would cost at least $248.8 million (300 billion).

 “We are doing this so that Korea will become an exemplary case for eradicating COVID-19.”

– Celltrion Chairman Seo Jung-jin, during the YouTube live stream

Celltrion is still pursuing to establish China’s biggest biologics drug plant in the city of Wuhan.

Tags: Celltrionclinical trialscoronavirusCOVID-19curediagnostic kitsSouth Korea

Related Posts

Supply Chain 2.0: How U.S.–Korea Trade Shifts Are Building a Resilient Tech Ecosystem
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
AI

Supply Chain 2.0: How U.S.–Korea Trade Shifts Are Building a Resilient Tech Ecosystem

October 31, 2025
Korea’s APEC Digital & AI Forum Highlights Asia’s Push for Responsible Tech Leadership
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
South Korea

Korea’s APEC Digital & AI Forum Highlights Asia’s Push for Responsible Tech Leadership

October 24, 2025
LG Uplus Bows to Pressure, Will Report Hacking Signs to Cybersecurity Watchdog
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
LG

LG Uplus Bows to Pressure, Will Report Hacking Signs to Cybersecurity Watchdog

October 22, 2025
South Korea Tightens Cyber Defenses After Detecting Government Hacking Attempt
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
Government

South Korea Tightens Cyber Defenses After Detecting Government Hacking Attempt

October 21, 2025
When Data Fails Trust: A Deep Dive into South Korea’s Escalating Breach Crisis
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
Editorial Feature

When Data Fails Trust: A Deep Dive into South Korea’s Escalating Breach Crisis

October 17, 2025
South Korea, BlackRock Team Up to Build Hyperscale AI Data Center Hub
Celltrion’s Chairman Seo Jung-jin, during a YouTube live stream, saying that the company doubled its efforts to create a super-fast test kit to identify COVID-19 and to develop a cure, with a human clinical trial stage in six months. / photo courtesy of Celltrion
Data Center

South Korea, BlackRock Team Up to Build Hyperscale AI Data Center Hub

October 1, 2025
No Result
View All Result

Most Popular

  • Ride-Hailing Rivalry: Kakao and Uber Bet on Membership Services in Korea

    0 shares
    Share 0 Tweet 0
  • Kakao Mobility Faces $10.5 Million Fine for Limiting Competitors’ Access to Taxi Platform

    0 shares
    Share 0 Tweet 0
  • Korea’s Navigation Battle Heats Up: Naver and Kakao vs. Google maps

    0 shares
    Share 0 Tweet 0
  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Naver Maps Launches Guide in English, Chinese, and Japanese to Enhance Travel Experience for Tourists

    0 shares
    Share 0 Tweet 0
  • Naver Unveils Asia’s Largest Data Center, GAK Sejong, for Tech Innovation

    0 shares
    Share 0 Tweet 0
  • Naver Video Streaming Service V Live to Go Global

    0 shares
    Share 0 Tweet 0
  • What SK Group’s ‘AI Now & Next’ Summit Reveals About the Future of Intelligent Korea

    0 shares
    Share 0 Tweet 0
  • South Korea’s $2.26 Billion Vision: A Robotic Revolution by 2030

    0 shares
    Share 0 Tweet 0
  • Hanwha Aerospace to Develop Indigenous Turboprop Engine for South Korea’s Next-Gen UAVs

    0 shares
    Share 0 Tweet 0

PRODUCTS

[ads_amazon]

TOPICS

  • Naver
  • Kakao
  • Nexon
  • Netmarble
  • NCsoft
  • Samsung
  • Hyundai

FREE NEWSLETTER

FOLLOW US

  • About Us
  • Cookie policy
  • home
  • homepage
  • mainhome
  • Our Services
  • Privacy Policy
  • Terms of Use

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists

Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : [email protected] |